Found: 27
Select item for more details and to access through your institution.
Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 131, doi. 10.1007/s10549-018-4827-6
- By:
- Publication type:
- Article
Genetic dissection of the BRCA2 promoter and transcriptional impact of DNA variants.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 53, doi. 10.1007/s10549-018-4826-7
- By:
- Publication type:
- Article
Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 217, doi. 10.1007/s10549-018-4818-7
- By:
- Publication type:
- Article
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 1, doi. 10.1007/s10549-018-4825-8
- By:
- Publication type:
- Article
Impact of high-deductible insurance on adjuvant hormonal therapy use in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 235, doi. 10.1007/s10549-018-4821-z
- By:
- Publication type:
- Article
Metastatic Breast Cancer Collateral Damage Project (MBCCD): Scale development and preliminary results of the Survey of Health, Impact, Needs, and Experiences (SHINE).
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 75, doi. 10.1007/s10549-018-4823-x
- By:
- Publication type:
- Article
Tamoxifen-induced fatty liver disease in a Caucasian patient.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 243, doi. 10.1007/s10549-018-4817-8
- By:
- Publication type:
- Article
Gene expression in triple-negative breast cancer in relation to survival.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 199, doi. 10.1007/s10549-018-4816-9
- By:
- Publication type:
- Article
The histone deacetylase inhibitor OBP-801 and eribulin synergistically inhibit the growth of triple-negative breast cancer cells with the suppression of survivin, Bcl-xL, and the MAPK pathway.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 43, doi. 10.1007/s10549-018-4815-x
- By:
- Publication type:
- Article
SNP rs2071095 in LincRNA H19 is associated with breast cancer risk.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 161, doi. 10.1007/s10549-018-4814-y
- By:
- Publication type:
- Article
Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 111, doi. 10.1007/s10549-018-4813-z
- By:
- Publication type:
- Article
Construction of a novel multi-gene assay (42-gene classifier) for prediction of late recurrence in ER-positive breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 33, doi. 10.1007/s10549-018-4812-0
- By:
- Publication type:
- Article
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 121, doi. 10.1007/s10549-018-4811-1
- By:
- Publication type:
- Article
Uptake of BRCA 1/2 and oncotype DX testing by medical and surgical oncologists.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 173, doi. 10.1007/s10549-018-4810-2
- By:
- Publication type:
- Article
Incidence and risk factors for congestive heart failure in patients with early breast cancer who received anthracycline and/or trastuzumab: a big data analysis of the Korean Health Insurance Review and Assessment service database.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 181, doi. 10.1007/s10549-018-4809-8
- By:
- Publication type:
- Article
Predictors of surveillance mammography outcomes in women with a personal history of breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 209, doi. 10.1007/s10549-018-4808-9
- By:
- Publication type:
- Article
Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 21, doi. 10.1007/s10549-018-4807-x
- By:
- Publication type:
- Article
Treatment-induced early menopause and the protective role of gonadotropin-releasing hormone agonists during chemotherapy.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 245, doi. 10.1007/s10549-018-4806-y
- By:
- Publication type:
- Article
Associations of dietary intake and supplement use with post-therapy cognitive recovery in breast cancer survivors.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 189, doi. 10.1007/s10549-018-4805-z
- By:
- Publication type:
- Article
Long-term survival in trastuzumab-treated patients with HER2-positive metastatic breast cancer: real-world outcomes and treatment patterns in a whole-of-population Australian cohort (2001-2016).
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 151, doi. 10.1007/s10549-018-4804-0
- By:
- Publication type:
- Article
Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 95, doi. 10.1007/s10549-018-4803-1
- By:
- Publication type:
- Article
Incorporation of the technologist’s opinion for arbitration of discrepant assessments among radiologists at screening mammography.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 143, doi. 10.1007/s10549-018-4800-4
- By:
- Publication type:
- Article
BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 85, doi. 10.1007/s10549-018-4797-8
- By:
- Publication type:
- Article
A double-blind, randomised trial of a polyphenolic-rich nail bed balm for chemotherapy-induced onycholysis: the UK polybalm study.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 103, doi. 10.1007/s10549-018-4788-9
- By:
- Publication type:
- Article
Effect of glucocorticoid use on survival in patients with stage I-III breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 225, doi. 10.1007/s10549-018-4787-x
- By:
- Publication type:
- Article
Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 65, doi. 10.1007/s10549-018-4785-z
- By:
- Publication type:
- Article
Use of cyclin-dependent kinase (CDK) 4/6 inhibitors for hormone receptor-positive, human epidermal growth factor receptor 2-negative, metastatic breast cancer: a roundtable discussion by The Breast Cancer Therapy Expert Group (BCTEG).
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 171, n. 1, p. 11, doi. 10.1007/s10549-018-4783-1
- By:
- Publication type:
- Article